Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow MSCs in Spinal Cord Injury
NCT02482194Phase 1Completed
- Sponsor
- National Institute of Blood and Marrow Transplant
- Start
- Jun 2013
- Primary completion
- Jan 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mesenchymal stem cells in spinal cord injury (SCI), sponsored by National Institute of Blood and Marrow Transplant. Primary endpoint: Number of adverse events at 1 month. Started Jun 2013; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02482194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02482194.